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The Hippo kinase pathway plays a central role in
growth regulation and tumor suppression from flies
to man. The Hippo/Mst kinase phosphorylates and
activates the NDR family kinase Warts/Lats, which
phosphorylates and inhibits the transcriptional acti-
vator Yorkie/YAP. Current models place the FERM-
domain protein Expanded upstream of Hippo kinase
in growth control. To understand how Expanded
regulates Hippo pathway activity, we used affinity
chromatography and mass spectrometry to identify
Expanded-binding proteins. Surprisingly we find
that Yorkie is the major Expanded-binding protein
in Drosophila S2 cells. Expanded binds Yorkie at
endogenous levels via WW-domain-PPxY interac-
tions, independently of Yorkie phosphorylation at
S168, which is critical for 14-3-3 binding. Expanded
relocalizes Yorkie from the nucleus, abrogating its
nuclear activity, and it can regulate growth down-
stream of warts in vivo. These data lead to a new
model whereby Expanded functions downstream of
Warts, in concert with 14-3-3 proteins to sequester
Yorkie in the cytoplasm, inhibiting growth activity of
the Hippo pathway.
INTRODUCTION
Understanding how cells regulate proliferation and apoptosis is
crucial for understanding developmental events, such as organ
size control, as well as disease conditions such as cancer, in
which the regulation of growth and apoptosis is lost. Studies in
recent years, primarily conducted in Drosophila, have implicated
the Hippo (Hpo) signaling pathway as a central mechanism that
regulates organ size by controlling both cell proliferation and cell
death (reviewed in Bandura and Edgar, 2008; Pan, 2007).
The Hpo pathway core consists of a kinase cascade in which
the Ste20-like kinase Hpo, facilitated by the WW-domain-con-
taining adaptor protein Salvador (Sav), phosphorylates and acti-Develovates the NDR family kinase Warts (Wts) (Pantalacci et al., 2003;
Tapon et al., 2002; Udan et al., 2003; Wu et al., 2003). Wts, facil-
itated by the Mob family protein Mats (Justice et al., 1995; Lai
et al., 2005; Wei et al., 2007), phosphorylates the transcriptional
coactivator Yorkie (Yki) (Huang et al., 2005; Oh and Irvine, 2008).
This phosphorylation provides a 14-3-3-binding site on Yki,
allowing 14-3-3 to shuttle Yki from the nucleus, inhibiting its
function (Dong et al., 2007; Oh and Irvine, 2008). Yki binds Scal-
loped (Bandura and Edgar, 2008; Goulev et al., 2008; Wu et al.,
2008; Zhang et al., 2008b), and possibly other transcription
factors, to regulate the expression of Cyclin E, Diap1, Fj, and
Bantam, promoting cell proliferation and inhibiting apoptosis
(reviewed in Bandura and Edgar, 2008; Edgar, 2006; Hariharan,
2006; Pan, 2007; Reddy and Irvine, 2008; Saucedo and Edgar,
2007; Zeng and Hong, 2008). Hpo pathway activation also leads
to increased transcription of upstream components such asmer
and ex, providing feedback inhibition of the pathway. Mutation of
hpo, sav, or wts, or overexpression of yki, results in massive
tissue overgrowth characterized by excessive cell proliferation
and diminished apoptosis.
The Hpo pathway plays a conserved role in organ size control
and tissue homeostasis in mammals. YAP, the mammalian
homolog of Yki, is upregulated in some tumors and can transform
immortalized mammary epithelial cells in vitro (Overholtzer et al.,
2006) andaccelerate tumorigenesis (Zenderet al., 2006).NF2, the
human counterpart of Mer, is a known tumor suppressor gene
whose mutations lead to neurofibromatosis (McClatchey and
Giovannini, 2005). The mammalian homologs of Hpo (MST1/2),
Sav (WW45), and Wts (Lats1/2) constitute a kinase cascade
that inactivates YAP function via similar phosphorylation events
(Dong et al., 2007; Hao et al., 2008; Praskova et al., 2008; Zhang
et al., 2008a; Zhao et al., 2007).
Whereas themolecular details of the core Hpo kinase cascade
have been well worked out, it is less clear how the activity of this
pathway is regulated. Current models propose that two
membrane-associated FERM-domain proteins, Expanded (Ex)
and Merlin (Mer), function as upstream components of the Hpo
pathway (Hamaratoglu et al., 2006; Zeng and Hong, 2008).
Hpo pathway activity is controlled in part by the large cadherin
Fat, which is proposed to recruit Ex to apical membranes (Ben-
nett and Harvey, 2006; Silva et al., 2006;Willecke et al., 2006). Expmental Cell 16, 411–420, March 17, 2009 ª2009 Elsevier Inc. 411
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Ex Binds Yki to Inhibit Hpo Growth SignalingFigure 1. Discrete Domains Regulate Ex Apical and Junctional
Localization
(A) Schematic of the Ex protein. Ex consists of an N-terminal FERM domain,
a linker region, and a C-terminal proline-rich domain.
(B–F) High magnification of lateral views of imaginal eye discs expressing
different GFP- or HA-tagged Ex constructs (green, [B]–[F]) and stained for actin
(Rhodamine-phalloidine, red, [B0]–[E0]). (B) Full-length Ex localizes apically and
is enriched to apical junctions. (C) The Ex FERM domain primarily localizes412 Developmental Cell 16, 411–420, March 17, 2009 ª2009 Elsevieconsists of an N-terminal FERM domain, a linker region, and
a C-terminal proline-rich domain (Figure 1A). Expression of the
C-terminal half of Ex in theDrosophilawing can suppress growth
(Boedigheimer et al., 1997), and mutations that truncate the C-
terminal domain are functionally null and lethal (Pellock et al.,
2007). How the C-terminal proline-rich region of Ex inhibits
growth remains unknown. In addition, it is unclear how the Hpo
signal is terminated, as 14-3-3 proteins, which can function to
shuttle Yki out of the nucleus, have the potential to shuttle Yki
back in, in the absence of a cytoplasmic anchor.
To address the biochemical basis of Ex regulation of growth
and apoptosis, we purified Ex-binding proteins from Drosophila
cells by using affinity chromatography coupled with mass spec-
trometry. Surprisingly, we find that the major Ex-binding protein
is Yki. We show that Ex binds Yki at endogenous levels and regu-
lates Hpo pathway activity downstream of wts in vivo. Ex func-
tions to relocate Yki from the nucleus to the cytoplasm, thus
inhibiting Yki transcriptional activity. We demonstrate that the
Ex-Yki interaction occurs via Yki WWdomains and three partially
redundant PPxY motifs in the Ex C-terminal domain. Binding of
Ex to Yki is independent of phosphorylation at S168, suggesting
that Ex can bind Yki in both phospho and dephosphorylated
forms. We propose a model whereby Ex functions in concert
with 14-3-3 proteins to sequester Yki in the cytoplasm, inhibiting
its activity in the regulation of growth and apoptosis.
RESULTS
In Vivo Analysis of Ex Localization Elements
Previous data have indicated that Ex localizes apically, with a
concentration at cell-cell junctions (Bennett and Harvey, 2006;
Boedigheimer and Laughon, 1993; McCartney et al., 2000; Silva
et al., 2006;Willecke et al., 2006). To determine which portions of
Ex function to mediate its localization, we adopted an in vivo
structure-function analysis. Transgenic Drosophila lines were
established expressing full-length Ex and Ex deletion constructs
tagged with GFP or HA (Figure 1A). Full-length Ex-HA shows
a localization pattern similar to that of endogenous Ex, with
a localization at apical surfaces of epithelial cells, and a concen-
tration at apical junctions (Figure 1B). A construct with only the
N-terminal FERM domain (aa 1–400) localizes most strongly to
the apical membrane domain (Figure 1C). The linker region (aa
400–747) mediates weak membrane localization (Figure 1D),
whereas the C-terminal region (aa 748–end) becomes strongly
localized to apical junctions (Figures 1E and 1F). These data indi-
cate that the N terminus, containing the FERMdomain, mediates
apical localization, that there is aweak apical localization element
located in the linker region, and that theC-terminal domain, previ-
ously identified as containing the growth-suppressive portions of
Ex, localizes to apical junctions.
Purification and Mass Spectrometric Identification
of an Ex-Yki Complex
To understand how Ex regulates Hpo kinase pathway activity,
we sought to identify Ex-binding proteins in Drosophila cells.
apically. (D) The Ex linker domain appears mostly cytoplasmic, with a weak
apical enrichment. (E and F) The Ex C terminus localizes apically, with an
enrichment near apical junctions.r Inc.
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Ex Binds Yki to Inhibit Hpo Growth SignalingFigure 2. Identification of Yki as an Ex-Binding Protein
(A) Identification of Ex-binding proteins. Ex was immunoprecipitated, by using anti-Flag antibody, from S2 cells transfected with Ex-Flag or Flag as a control.
Proteins coimmunoprecipitating with Ex-Flag or Flag were silver stained in a polyacrylamide gel. Arrows indicated two bands isolated from cells expressing
Ex-Flag, but not in the control, running at the expected sizes of Ex and Yki.
(B) Yki coimmunoprecipitates with Ex-Flag. S2 cells were transfected with Ex-Flag and V5-Wts as indicated on top, and a-Flag immunoprecipitates were probed
with a-Flag (Ex), a-Yki, a-Hpo, and a-V5 (Wts). One-tenth of the cell lysates used for immunoprecipitation were probed with the same antibodies as control. Note
that Yki, but not Hpo or Wts, coimmunoprecipitates with Ex.
(C) Ex and Yki interact at endogenous levels. Yki immunoprecipitates from untransfected S2 cells were subjected to western blot with a-Ex. Note that endogenous
Ex coimmunoprecipitates with Yki, and not with the control IgG.
(D) Junctional localization in the eye disc. Highmagnification of third-instar eye imaginal discs stained for Actin (red), Armadillo (green), and DAPI (blue) to illustrate
the morphology of the eye imaginal disc when viewed from the side. Apical is facing up (marked by an arrow), and junctional clusters are highlighted by Armadillo
(marked by an asterisk).
(E) Yki and Ex colocalize at apical junctions. Yki (red), Ex (blue), and the junctional marker Armadillo (green). As in (D), except that the discs were permeablized
before fixation and stained with Yki and Ex. The pictures represent a lateral view of an eye imaginal disc; the apical membrane is on top. The single channels are
represented in black and white for Ex and Yki. Note that Ex and Yki partially colocalize apically.Drosophila S2 cells were transfected with Flag-tagged Ex. Ex
and its interacting proteins were immunoprecipated by using
Flag antibody. S2 cells transfected with the Flag empty vector
were used as a control. Elution from Flag-agarose beads (see
Experimental Procedures) was conducted in phosphoric acid.
A nano-LC/MS/MS analysis was performed on the tryptic digest
of the proteins associated with the immunoprecipitate in a gel-
free approach.
Table S1 reports the proteins found uniquely in the Ex-trans-
fected sample and not in controls. Surprisingly, one of the
most abundant coimmunoprecipitating proteins, detected with
the highest spectral counts, is Yki, detected with a high number
of peptides and a good level of sequence coverage in all exper-
iments. Consistent with our mass spectrometry results, silver-
stain analysis of the eluates revealed the presence of two major
bands specific to the Ex-Flag immunoprecipitates: A band at
200 kDa corresponds to Ex-Flag, and a 50 kDa band corre-
sponds to Ykimolecular size (Figure 2A).We confirmed by immu-
noblot the presence of endogenous Yki immunoprecipitating
with Ex-Flag in S2 cells, whereas other components of the HpoDevelopathway, such as Hpo andWts, were not present in the immuno-
precipitates (Figure 2B and data not shown).
To determine if the interaction between Ex and Yki can occur
at physiological levels, we tested whether endogenous levels of
Ex and Yki coimmunoprecipitate in Drosophila S2 cells. Indeed,
western blot analysis of Yki immunoprecipitates demonstrated
that Ex also coimmunoprecipitates with Yki from untransfected
S2 cells, showing that these proteins can interact at endogenous
levels (Figure 2C).
To determine if there is a population of Yki that colocalizes with
Ex in vivo, we examined Yki and Ex localization in the eye imag-
inal disc, by using antibodies against the endogenous proteins.
Ex localizes strongly to apical junctions in Drosophila imaginal
discs (Figure 1). Strikingly, a population of Yki is found near the
apical cortex, colocalizing with Ex (Figures 2D and 2E and data
not shown). Treatment of the discs with Triton X-100 before fixa-
tion confirmed that a population of Yki is membrane associated
and colocalized with Ex at apical junctions (Figure 2E). Taken
together, these results strongly suggest that Ex and Yki interact
in vivo.pmental Cell 16, 411–420, March 17, 2009 ª2009 Elsevier Inc. 413
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Ex Binds Yki to Inhibit Hpo Growth SignalingFigure 3. The PPxY Motifs of Ex Bind Yki WW Domains
(A) Yki directly binds Ex. Bacterially expressedGST-Yki bound to glutathione Sepharose beadswas incubatedwith the purified His-tagged ExC terminus (His-Ex-
CT). Proteins associating resin-bound Yki were immunoblotted and probed with a-His to detect Ex. One-tenth of the Ex proteins used for the pull-down was
probed with a-His as a control (input). Note that the C-terminal region of Ex interacts with Yki, and not with a GST-tagged fragment of the intracellular part of
Fat used as a negative control (GST-Ctl).
(B) Yki structure. Yki contains twoWWdomains and is phosphorylated byWts on S168. Yki-N and Yki-C are the deletion constructs used for the pull-down assay.
(C) Ex binds the Yki C terminus. GST-Yki mutants, bound to glutathione Sepharose beads, were incubated with the purified His-tagged Ex C terminus (His-Ex-
CT). Note that Ex is pulled down by the Yki C terminus (lane 4), but not by the N terminus (lane 3).
(D) Mutations in the WW domains of Yki disrupt interaction with Ex. Same pull-down experiments as in (C), with different Yki mutants. Mutation of the Wts phos-
phorylation site of Yki, S168A, does not disrupt the interaction with Ex (lane 4). Yki WW domains were disrupted by substituting two critical amino acids with
alanine. Disruption of both WW domains, DWW1 and DWW2, inhibits binding with Ex (lane 5), whereas disruption of only one of them (DWW1 and DWW2)
decreases but does not abrogate the interaction (lane 6 and 7).
(E) Mutations in the PPxY motifs of Ex disrupt interaction with Yki. Mutation of the three PPxY motifs were introduced in the Ex C-terminal construct by mutating
the critical tyrosine of each motif into an alanine (Ex3Y). This mutant and the wild-type Ex-CT were incubated with GST-Yki, and the pulled-down samples were
probed with a-His. Note that Ex3Y does not associate with GST-Yki (lane 8).
(F) S2 cells were transfected with Ex-Flag or Ex3Y-Flag, and a-Yki immunoprecipitates were probed with a-Flag (Ex) and a-Yki. One-tenth of the cell lysates used
for the immunoprecipitation was probed with the same antibodies. Contrary to the wild-type Ex, Ex3Y does not coimmunoprecipitate with Yki.414 Developmental Cell 16, 411–420, March 17, 2009 ª2009 Elsevier Inc.
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Ex Binds Yki to Inhibit Hpo Growth SignalingEx Binds Directly to Yki
To determine if Ex directly interactswith Yki, we used in vitro pull-
down assays with proteins purified from bacteria. Pull-down
experiments revealed that Ex can directly bind Yki (Figure 3A).
Todeterminewhichportionof ExbindsYki,wegeneratedaseries
of Ex deletion constructs tagged with a histidine epitope tag.
These studies demonstrated that the C-terminal part of Ex (His-
Ex-CT) is able to bind GST-Yki in vitro, whereas the N-terminal
part of Ex does not (Figure 3A; see Figure S1B available online).
Moreover, we confirmed by immunoprecipitation in S2 cells
that a Flag-tagged C-terminal Ex, but notDCT-terminal Ex, binds
Yki (Figure S1A). Thus, the Yki-binding region of Ex maps to the
C-terminal domain, which has been previously shown to be
essential for growth regulation in vivo.
The PPxY Motifs of Ex Bind Yki WW Domains
Yki contains two WW domains in its C-terminal region, which
bind Wts (Huang et al., 2005), allowing Wts to phosphorylate
Yki on Serine 168. This phosphorylation generates a 14-3-3-
binding site, enabling 14-3-3 to shuttle Yki out of the nucleus
(Dong et al., 2007; Zhao et al., 2007). To determine if Wts phos-
phorylation of Yki is required for the binding between Ex and Yki,
we generated a nonphosphorylatable GST-Yki in which Serine
168 was replaced by an alanine (GST-Yki S168A). This mutant
binds His-Ex-CT as efficiently as wild-type in vitro, demon-
strating that Yki phosphorylation on S168 is dispensable for Ex
binding (Figure 3D, lane 4).
To map the regions in Yki responsible for interaction with Ex,
we performed pull-down assays with purified GST-Yki fusion
proteins containing different deletions constructs. We observed
that the N-terminal region of Yki (aa 1–295) does not bind Ex
(Figure 3C, lane 3). In contrast, the C-terminal region of Yki (aa
206–418), which includes both WW domains, binds strongly to
Ex (Figure 3C, lane 4).
To determine if one or both of Yki’s WW domains are respon-
sible for binding to Ex, we mutated two critical residues of the
WW domains, disrupting one (DWW1 [W292A/P295A] or DWW2
[W361A/P364A]) or both (DWW1 and DWW2 [W292A/P295A/
W361A/P364A]) domains. Disruption of both WW domains in
Yki abrogates its binding to Ex, whereas both single WWdomain
disruptions induce only a decrease in Ex binding (Figure 3D,
lanes 5–7). These results suggest that both WW domains of Yki
are needed for efficient binding to Ex.
The WW domains of the human ortholog of Yki, the Yes-Asso-
ciated protein, YAP, belongs to a subgroup of WW domains that
are known to specifically bind PPxY motifs (Macias et al., 2002).
Interestingly, three of thesemotifs can be found in the C-terminal
region of Ex (aa 786–789, 844–847, and 1203–1206: see
Figure S2). To test the role of the PPxY motifs in Yki binding,
the critical tyrosine residue of each motif was mutated into an
alanine (Ex3Y). Using GST pull-down assays, we found that
Ex3Y is no longer able to bind Yki, suggesting that these PPxY
motifs are critical for interaction with Yki WW domains
(Figure 3E, lane 8). Moreover, we find that a Flag-tagged versionDeveloof Ex3Y expressed in S2 cells is not coimmunoprecipitated with
endogenous Yki, whereas the wild-type version of Ex is effi-
ciently precipitated with Yki (Figure 3F).
Our structure-function analysis revealed that Ex, like Wts,
binds to the WW domains of Yki, suggesting that the interaction
of Ex andWts with Yki may bemutually exclusive. To directly test
whether Ex and Wts function competitively in binding Yki, we
examined if the Yki-Wts coimmunoprecipitation is affected by
expressing increasing amounts of Ex. When an increasing
amount of Ex is expressed in cells, the coimmunoprecipitation
of Ex with Yki increases, whereas the amount of Wts coimmuno-
precipitated with Yki decreases (Figure 3G). Taken together with
our observation that Wts was not present in Ex immunoprecipi-
tates (Figure 2B), these data suggest that Ex and Wts may
compete for binding to Yki. Interestingly, increasing levels of
Ex markedly compete Wts-Yki binding (Figure 3G), whereas
increasing Wts is less effective in inhibiting Ex-Yki binding
(Figure 2B), suggesting that the Ex-Yki interaction is stronger
than the Yki-Wts interaction.
Ex Inhibits Yki Transcriptional Activity in S2 Cells
To test the consequences of the Yki-Ex interaction on Yki
activity, we used a well-established transcriptional assay (Huang
et al., 2005). This assay relies on a fusion protein of the Gal4-
DNA-binding domain with Yki that can activate a UAS-luciferase
reporter in S2 cells. The luciferase activity, which reflects Yki
cotranscriptional activity, is reduced by the expression of Ex or
other members of the Hpo pathway (Hamaratoglu et al., 2006;
Huang et al., 2005) (Figure 4). We found that the C-terminal
domain of Ex, responsible for Yki binding, is necessary and suffi-
cient to strongly decrease Yki activity in this assay (Figures 4B
and 4C), suggesting that the N-terminal part of Ex may be
responsible for the regulation of Ex activity (Figure 4B). To iden-
tify the Yki-inhibiting domain in the C-terminal part of Ex, we first
subdivided it into two parts, CT1 and CT2, and tested their
effects on Yki transcriptional activity (Figure 4A). This assay
revealed that both CT1 and CT2 are able to decrease Yki activity;
however, they are less effective than the entire C terminus
(Figure 4C). Addition of CT1 and CT2 led to increased transcrip-
tional inhibition. The PPxY motifs involved in Yki binding are
found both in CT1 and CT2 (Figure 4A). To test the role of these
motifs in the inhibition of Yki activity, we used the Yki-binding
mutant Ex3Y. Ex3Y is significantly less potent than wild-type Ex
in repressing Yki activity, supporting a role for these Yki-binding
motifs in Yki inhibition (Figure 4D).
Theobservation that theC-terminal domain of Ex,with itsPPxY
motifs, directly binds Yki (Figure 3A), and inhibits its cotranscrip-
tional activity in S2 cells (Figures 4B and 4C), suggests that Ex
might be able to inhibit Yki directly, in an Hpo/Wts-independent
fashion.
To test this hypothesis, we first askedwhether the suppression
of Yki activity by Ex required Hpo. We observed that knockdown
ofHpobyRNAi fails to rescue the decrease in Yki activity induced
by Ex, despite a dramatic decrease in Hpo levels after RNAi(G) Ex-Yki and Wts-Yki interactions are mutually exclusive. S2 cells were transfected with V5-Wts, HA-Yki, and an increasing amount of Ex-Flag plasmids, and
a-HA immunoprecipitates were probed with a-V5 (Wts), a-HA (Yki), and a-Flag (Ex). One-tenth of the cell lysates used for the immunoprecipitation was probed
with the same antibodies. Note that increasing amounts of Ex decrease the amount of Wts coimmunoprecipitating with Yki.pmental Cell 16, 411–420, March 17, 2009 ª2009 Elsevier Inc. 415
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Ex Binds Yki to Inhibit Hpo Growth Signalingtreatment (Figure 4E). The same treatment is able to inhibit the
effects of Hpo on Yki activity (Figure 4E). Thus, the effects of Ex
on Yki activity, at least in S2 cells, appears to be Hpo indepen-
dent.
Ex Expression Relocalizes Yki to the Cytoplasmic
Compartment
We next observed the consequences of Ex expression on Yki
localization by expressing tagged versions of Ex and Yki in S2
cells. Yki expressed in S2 cells can be observed both in the
nucleus and the cytoplasm (Figure 4F). In contrast, Ex expressed
in S2 cells is predominantly cytoplasmic, with a component that
is enriched at the plasma membrane (Figure 4G). Coexpression
of Ex with Yki results in a dramatic relocalization of Yki to the
cytoplasmic compartment (Figures 4G). We confirmed that this
occurs with the DBD-Gal4-Yki fusion protein used in the tran-
scription assay aswell (Figure S3), and in both cases quantitation
reveals that this alteration in localization is statistically significant
Figure 4. Ex Inhibits Yki Transcriptional Activity in S2 Cells
(A) Representation of Ex structure, with an indication of the different deletion
constructs.
(B–D) S2 cells were transfected with UAS-luciferase plasmid along with plas-
mids expressing the Gal4 DNA-binding domain fused to yki and plasmids
expressing hpo or different ex mutants as indicated on the bottom. Graphs
represent luciferase activity normalized with an internal control (Renilla lucif-
erase); error bars represent standard deviation. Note that the Ex C terminus
is necessary and sufficient to decrease Yki transcriptional activity, and that
Ex3Y is less potent than the wild-type at inhibiting Yki transcriptional activity.
(E) S2 cells were transfected as in (B)–(D) and treated with a specific hpo
dsRNA. In addition to the luciferase assay, a western blot was performed
and probed with a-Hpo. Note that Hpo quantity is largely decreased after
dsRNA treatment, and that Yki inhibition by Ex is Hpo independent.
(F and G) S2 cells transfected with (F) Yki-HA or (G) Flag-Ex and Yki-HA were
subjected to immunofluorescence with a-Flag (Ex, red) and a-Yki (green) anti-
bodies andDAPI (nucleus, blue). Note that coexpression of Ex leads to a reduc-
tion in Yki nuclear staining.416 Developmental Cell 16, 411–420, March 17, 2009 ª2009 Elsevie(Figure S4). This relocalization of Yki away from the nucleus
provides amechanistic explanation for the ability of Ex to repress
Yki transcriptional activity. Consistent with this finding in S2
cells, reducing the levels of Ex in the posterior compartment of
wing discs, by using UAS-ExRNAi and Engrailed-Gal4, leads to
increased levels of nuclear Yki (Oh and Irvine, 2008) (Figure S5).
Ex Regulates Growth In Vivo Downstream of wts
Taken together, these data lead to amodel in which Ex can func-
tion in parallel to or downstream of Wts to regulate Yki transcrip-
tional activity. To determine if this is true in vivo, we examined the
effects of expressing Ex in the eye imaginal disc in a wtsmutant
background. Mutations in hpo or wts lead to an overgrowth
phenotype characterized by overexpression of the Yki transcrip-
tional targets Cyclin E and DIAP1 (Hansen et al., 2003; Huang
et al., 2005; Pantalacci et al., 2003; Tapon et al., 2002; Udan
et al., 2003). Using the MARCM system, we analyzed the effect
of expression of Ex in wts mutant clones in developing
Drosophila eye discs. As previously reported, induction of wts
mutant clones results in a dramatic overgrowth phenotype,
with the mutant cells covering almost the entire eye disc. The
overgrowth phenotype is clearly visible, as the wts mutant eye
disc appeared deformed, with a folded excessive epithelium in
third-instar larval eye imaginal discs (Figure 5A). If Ex regulates
Yki only through the activation of Wts, its overexpression in
wts mutant clones should have no effect. On the contrary, we
observed that expression of Ex largely rescues the overgrowth
phenotype induced by wts mutation (Figure 5B). In fact, this
suppression is so dramatic that late third-instar eye discs are
not drastically deformed but retain a more normal shape (Fig-
ure 5B). These data indicate that Ex can function downstream
of wts to regulate growth in the eye imaginal disc.
Wenext examined the ability of Ex to regulate the expression of
a known transcriptional target of Yki, Cyclin E.Cyclin E is normally
expressed in a narrow stripe of cells posterior to the morphoge-
netic furrow (arrowhead: Figure 5C). Overexpression of Cyclin E
is clearly visible in wts tissue at early third instar as a dramatic
broadening of the expression domain of Cyclin E (white brackets:
Figure 5D). Strikingly, expression of Ex largely rescues Cyclin E
overexpression in wtsmutant tissue (Figure 5E). The overgrowth
of the imaginal discs induced bywts clones leads to a lethality at
the pupal stage in all animals (Figure 5F). Expression of Ex inwts
mutant clones leads to significant rescue of the pupal lethality
induced by loss of wts (Figure 5F). Therefore, Ex can function
downstream of wts, both in the regulation of the Hpo pathway
target Cyclin E, and in blocking the lethality induced by the unre-
strained overgrowth of wtsmutant cells.
We next tested if expression of the C-terminal region of Ex,
responsible for Yki binding, was also able to rescue thewts over-
growth phenotype, and we found that the C-terminal domain of
Ex is even more potent than full-length Ex in blocking the over-
growth of wts clones, rescuing both Cyclin E overexpression
and lethality (Figure 5F and data not shown). As a control, we
tested the expression of another portion of Ex, the loop domain
(also known as the linker domain; between the FERM domain
and the C terminus) (Figure S2). Expression of the loop is not
able to rescue the wts mutant phenotype, and it showed no
detectable rescue of either growth or Cyclin E expression
(Figure 5F and data not shown).r Inc.
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Ex Binds Yki to Inhibit Hpo Growth SignalingThese results strongly suggest that Ex is able to regulate
growth by inhibiting Yki directly, independent of Hpo/Wts kinase,
both in vitro and in vivo. Taken together, these data suggest
a model in which the binding of Ex to Yki leads to reduced levels
of Yki in the nucleus, thereby terminating growth promotion and
apoptosis inhibition by the Hpo pathway (Figure S6).
DISCUSSION
The Hpo pathway has recently emerged as a central mechanism
that restricts organ size in Drosophila and controls tissue growth
and cancer susceptibility in mammals. Here, we provide several
Figure 5. Ex Regulates In Vivo Growth Downstream of wts
(A and B) Third-instar eye imaginal discs containing (A)wtsx1 clones or (B) wtsx1
clones overexpressing Ex-GFP obtained by using the MARCM technique. /
clones were marked by the presence of GFP. Note that the overgrowth and the
‘‘undulating’’ shapephenotypeofwtsx1clonesare rescuedbyExoverexpression.
(C) Wild-type eye imaginal disc stained with a-Cyclin E. A thin band of cells
along the morphogenic furrow (MF) stain positively for Cyclin E (the arrowhead
marks the location of the MF).
(D–E00) Third-instar eye imaginal discs containing (D) wtsx1 clones or (E) wtsx1
clones overexpressing Ex-GFP. / clones were marked by the presence of
GFP (D and E), and discs were subjected to immunostaining with a-Cyclin E
(D0 and E0). The range of Cyclin E expression is greatly increased in the wtsx1
clone (compare the size of the bracket within the clone versus that outside of
the clone [D0]) and is rescued by the overexpression of Ex. Note some nonau-
tonomous proliferation is induced by wts clones in the presence or absence
of Ex. (D00) and (E00) represent an overlay of GFP and Cyclin E expression.
(F) Table summarizing the recovery of adults flies with the indicated genotypes.
A total of 25% of flies with the correct genotypes are expected in each case.
Note that Ex and Ex-CT rescue the lethality induced by wtsx1 clones.Develolines of evidence demonstrating that Ex functions to regulate the
Hpo pathway by direct binding of Yki, antagonizing Yki function
by inhibiting its nuclear localization.
Current models propose that ex and mer function together to
restrict tissue growth upstream of hpo (Edgar, 2006; Hamarato-
glu et al., 2006; Hariharan, 2006; McCartney et al., 2000; Pan,
2007; Saucedo and Edgar, 2007). Mer and Ex colocalize with
cortical actin in the apical region of the cell (Boedigheimer and
Laughon, 1993; Boedigheimer et al., 1997; McCartney et al.,
2000). Both genetic and physical interactions have been
observed between Mer and Ex: loss of one copy of mer domi-
nantly enhanced wing overgrowth in ex mutants. In addition,
fragments of Mer and Ex protein can interact physically with
each other in far-western experiments or when overexpressed
in cultured cells (McCartney et al., 2000). Clones doubly mutant
former and ex have more dramatic overgrowth than either single
mutant (Hamaratoglu et al., 2006; Maitra et al., 2006), andmer,ex
double mutants phenocopy hpo mutants.
However, despite the widespread acceptance that ex andmer
function upstream of Hpo (Edgar, 2006; Hamaratoglu et al.,
2006; Pan, 2007; Saucedo and Edgar, 2007; Zeng and Hong,
2008), some data are difficult to reconcile with ex acting strictly
upstream of hpo in activation of the pathway. Genetic analysis
indicates that ex is downstream of dachs, which has been shown
to be directly upstream ofwts in growth control (Cho et al., 2006).
Biochemical analysis of the effects of overexpressing Mer and
Ex also suggested that ex may not act simply upstream of hpo.
For example, overexpression of Mer in S2 cells leads to a shift
in Wts mobility, whereas overexpression of Ex does not alter
Wts mobility (Hamaratoglu et al., 2006). In vivo analysis has
also suggested that mer and ex may have different roles in
controlling growth and apoptosis (Blaumueller and Mlodzik,
2000; Pellock et al., 2007).
Using biochemical purification and mass-spectrometic anal-
ysis, we identified Yki as amajor Ex-binding protein inDrosophila
S2 cells. We demonstrate that the binding of Yki to Ex is direct
and is mediated by a WW domain-PPxY interaction. We further
show that this interaction is independent of Wts-dependent
phosphorylation at S168, a site previously shown to be essential
for strong interactions of Yki with 14-3-3 proteins. Consistent
with our biochemical analysis, we show that ex can act down-
stream of wts in the regulation of growth in eye imaginal discs
and can repress the pupal lethality caused by excessive growth
of wts clones. In addition, we find that loss of hpo does not alter
the ability of ex to regulate yki activity, as indicated by transcrip-
tional assays in S2 cells, and that expression of Ex is sufficient to
relocalize Yki to the cytoplasm. These data lead to a model in
which Ex functions to repress Yki activity at least in part by
keeping Yki out of the nucleus. Intriguingly, the Yki homolog,
YAP, was first identified as a protein that binds Src family kinases
at the cell membrane (Sudol, 1994). Subsequent studies have
focused on the role of Yki in the nucleus. Interestingly, our immu-
nohistochemical analysis reveals that a portion of Yki colocalizes
with Ex at the cell membrane in Drosophila imaginal discs.
Once Yki is phosphorylated byWts, it can bind 14-3-3 proteins
and can be transported out of the nucleus. However, since 14-3-
3-bound Yki can also shuttle back into the nucleus, Ex binding
Yki provides an anchor that can effectively dampen Yki activity.
14-3-3 shuttling activity results in an equilibrium of distribution ofpmental Cell 16, 411–420, March 17, 2009 ª2009 Elsevier Inc. 417
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biased in favor of Yki in the cytoplasm in the presence of Ex
acting as an anchor. The presence of a tether of Yki in the cyto-
plasmwas already suggested (Oh and Irvine, 2008) based on the
distribution of YkiS168A between the cytoplasm and the
nucleus, instead of predominantly in the nucleus.
The strong nuclear localization of Yki is only seen inDrosophila
tissues in cases of pathological stimulation of growth, such as in
wts loss-of-function clones, which lead to massive overgrowth.
The lack of detectable Yki nuclear localization during normal
growth regulation suggests that Yki is an exceedingly potent
growth regulator, and points to why there are many layers of
regulation of Yki localization. The need for Ex to dampen Yki
signaling in the nucleus is reflected by the increase of Cyclin E
and Diap1 transcription in ex mutant clones.
We speculate that the regulation of the Hpo pathway by
combined loss of Ex and Mer is so potent because one acts as
the brake and the other controls the accelerator. Ex restricts
Yki to the cytoplasm, thus blocking activity downstream,
whereas Mer activates Hpo activity, thereby restricting Yki via
inhibitory phosphorylation. Thus, loss of Ex on its own does
not have a dramatic effect on cell proliferation and apoptosis,
since the activity of the kinase cascade is regulated via Mer.
Conversely, as long as Ex is present, excessive pathway activity
induced by loss of Mer can be effectively modulated by the
dampening activity of Ex.
Our data strongly suggest that Ex regulates Yki activity down-
stream of wts, by directly binding Yki and inhibiting Yki nuclear
localization and transcriptional activity. We cannot, however,
exclude the possibility that Ex also has additional upstream roles
in regulating Hpo activity. Interestingly, as previously shown
(Hamaratoglu et al., 2006), overexpressed Ex does not induce
apoptosis in a wts mutant background, although it can block
growth (Figure S7), suggesting that ex is upstream of wts in
apoptosis control, yet downstream of wts in growth control.
Genetic dissection of this pathway is complicated by the well-
documented feedback loops in the Hpo pathway: for example,
Yki regulates the expression of both mer and ex. In addition,
genetic evidence suggests that ex and mer function together
to regulate endocytosis and growth factor signaling (Maitra
et al., 2006). Further biochemical dissection of Hpo pathway
activity will be required to fully elucidate the diverse ways in
which growth and apoptosis are controlled in response to
various developmental and environmental signals.
The binding of Ex to Yki is likely to be 14-3-3 independent, as
mutation of S168, the predominant Wts phosphorylation site,
impairs 14-3-3 binding, yet does not affect the ability of Ex to
bind Yki. Thus, Ex binding to Yki could provide a pool of Yki
that is nonphosphorylated and poised for release by upstream
growth regulators. The binding of 14-3-3 to Yki can protect Yki
from dephosphorylation. This provides a problem for the cell,
since 14-3-3 must dissociate from Yki to allow it to become
dephosphorylated, thus releasing a potent activator of prolifera-
tion and inhibitor of cell death, allowing it to re-enter the nucleus.
The ability of Ex to bind both phosphophorylated and dephos-
phorylated Yki provides a mechanism by which to anchor
dephosphorylated Yki in the cytoplasm.
An appealing model is that the binding of Ex to Yki may be
modulated, once in the cytoplasm, as an additional control point418 Developmental Cell 16, 411–420, March 17, 2009 ª2009 Elseviefor the Hpo pathway. FERM-domain proteins frequently form
inhibitory intramolecular associations, blocking the activity of
the protein until the repression is relieved. Modifications of the
Ex FERM domain or linker region could thus alter the ability of
Ex to bind Yki in vivo. Ex localization at apical junctions is at least
partially dependent upon the atypical cadherin Fat, which can
regulate Hpo pathway activity. The recruitment of Ex complexes
(directly or indirectly) to Fat may modify the ability of Ex to
interact with Yki.
Our in vivo analysis indicates that the N-terminal FERM
domain of Ex contains apical localization elements, whereas
the C-terminal region contains junctional localization elements.
Thus, each of these localization elements might be regulated
independently and might impact on the ability of Ex to sequester
Yki. Identification of which protein(s) Ex binds at junctions may
illuminate the mechanisms by which Ex responds to external
inputs to regulate Yki activity.
All of the components of the Hpo pathway are well conserved
in mammals and have been shown to have conserved functions
in regulating growth. Loss of Hpo andWts orthologs and overex-
pression of the Yki ortholog, YAP, have been implicated in
a variety of human cancers. FERM6, the human ortholog of Ex,
also regulates Hpo pathway activity (Zhao et al., 2007) in
mammals. Future studies will determine if FERM6 directly binds
YAP, and if disrupting YAP-FERM6 interactions is a tumor-
promoting event.
EXPERIMENTAL PROCEDURES
Molecular Biology
Full-length Ex, the FERM domain (aa 1–400), the linker region (aa 400–747),
and the C-terminal region (aa 748–end) were cloned into pAFW and pAWF
for expression of Flag-tagged proteins in S2 cells, and into pPGW and
pPHW for expression of GFP- and HA-tagged proteins in flies. N-terminal
Flag-tagged CT1 (aa 748–1136) and CT2 (aa 1129–end) were cloned into
pAc5.1. The Ex C terminus and N terminus (aa 1–747) were cloned in
pEXP1-DEST for expression in bacteria. Mutagenesis of the PPxY domains
of Ex was conducted by PCR; tyrosines 789, 847, and 1206 were changed
to alanines. Yki was clone into pGEX4T1 to express a GST-tagged protein in
bacteria. Mutagenesis of the WW domains of Yki was conducted by PCR,
and a critical tryptophan and proline were mutated into alanine, for one
(DWW1 [W292A/P295A] or DWW2 [W361A/P364A]) or both (DWW1 and
DWW2 [W292A/P295A/W361A/P364A]) domains.
Cell Culture and Immunoprecipitation
Drosophila S2 cells, cultured in S2 insect media (Sigma) containing 10% fetal
bovine serum (HyClone) and antibiotics, were transiently transfected by using
Effectine (QIAGEN) andwere collected 48hr or 72 hr after transfection.Western
blots were performed according to standard protocols. Antibodies used were
mouse a-Flag (1:10000, Sigma), rabbit a-Yki (1:1000, D. Pan), rat a-Yki
(1:3000), rabbit a-Hpo (1:6000), mouse a-V5 (1:1000, Invitrogen), rabbit a-Ex
(1:1000, A.S. Laughon), and mouse a-His (1:6000, Sigma). a-Yki antibody
was raised in rat against native GST-tagged protein, and a-Hpo was raised in
rabbit against the peptide CTTAKNNDDQKPRNR. Cells were lysed in buffer
(150 mM Tris [pH 7.5], 1 mM EDTA, 0.5% NP40, 0.2 mM PMSF, 1 mM EGTA,
and protease cocktail inhibitor [Roche]),and proteins were immunoprecipi-
tated. Rat a-Ykiwas added to the cell lysate for 2 hr at 4Candwasprecipitated
by adding protein glutathione Sepharose (GE Healthcare) for 1 hr. Ex-Flag
immunoprecipitation was performed by using a-Flag M2 agarose (Sigma),
and HA-Yki was performed by using rat a-HA affinity matrix (Roche), incubated
for 1 hr at 4C. SDS sample buffer was added after three washes of the beads
with the lysis buffer. Ex coimmunoprecipitating proteins were analyzed by LC-
MS-MS, as described in Supplemental Experimental Procedures.r Inc.
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Gal4 plasmid with 2 ng UAS-luc and 1 ng renilla plasmids, with or without Ex or
Hpo plasmids in 96-well plates (5 wells per condition). Luciferase assays were
performed by using the Dual Luciferase Reporter Assay System (Promega).
For hpo knockdown, dsRNAs were synthesized with the MEGAscript RNAi
kit (Ambion), from PCR products with the primers described by Willecke
et al. (2006). Cells were incubated with 2 mg dsRNA per well in 50 ml
Schneider’s medium in 96-well plates. After 2 hr, 50 ml Schneider’s medium
containing 20% FBS was added to each well.
GST Pull-Down
His-tagged ex and GST-yki plasmids were transformed and amplified in BL21
bacteria, and protein production was induced by IPTG. His-tagged Ex proteins
were purified by using nickel beads (QIAGEN) and were eluted with a 10 mM
imidazole buffer. GST-Yki proteins were purified from bacteria by using gluta-
thione Sepharose beads (Amersham, Biosciences). His-tagged Ex proteins
were incubated with GST-Yki bound in glutathione beads in pull-down buffer
(20 mM Tris, 1 mM EDTA, 1% Triton X-100, 1 mM b-meraptoethanol) for
45 min at room temperature or for 2 hr at 4C. Beads were then washed three
times in pull-down buffer before adding the sample SDS buffer.
Drosophila Genetics and Immunohistochemistry
Drosophila stocks used in this study were y,w1118 (wild-type) and wtsx1 (Xu
et al., 1995). We used the MARCM technique (Lee and Luo, 2001) to examine
wtsx1 clones alone or clones expressing ExFL or ExCTerm by using (1) eyFLP,
UAS-mCD8::GFP; tubGal80 FRT 82b, tubGal4/UAS-ExFL, wtsx1 FRT 82b; (2)
eyFLP, UAS-mCD8::GFP; tubGal80 FRT 82b, tubGal4/UAS-ExFL, wtsx1 FRT
82b; and (3) eyFLP, UAS-mCD8::GFP; tubGal80 FRT 82b, tubGal4/UAS-
ExCT, wtsx1 FRT 82b, respectively. Imaginal discs were fixed and stained
by following standard procedures. The primary antibodies used were mouse
a-Arm (1:400, DSHB), rabbit a-Ex (A.S. Laughon), rat a-Yki, rabbit a-Yki
(D. Pan), rabbit a-Casp3ACT (Cell Signaling Technology), and rat a-Cyclin E.
Actin was stained with rhodamine phalloidin (Invitrogen-Molecular Probes).
SUPPLEMENTAL DATA
Supplemental Data include seven figures, one table, Supplemental Experi-
mental Procedures, and Supplemental References and can be found with
this article online at http://www.cell.com/developmental-cell/supplemental/
S1534-5807(09)00038-0.
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